In recent years, several studies have shown high concentrations of CD147 expressed in laryngeal cancer [25], oral cancer [26], lung cancer [27], breast cancer [28], myeloma [29], and colon cancer [30], which indicates that CD147 serum levels may be correlated with the development, invasion, and metastasis of tumor cells [31–33]. Here, BSG is linked to lung carcinoma.